The global Electroencephalography (EEG) devices market size was valued at USD 995.3 million in 2020 and is anticipated to grow at a CAGR of 8.6% during the forecast period. Electroencephalography devices are widely used for analyzing the electrical activity of the brain, and diagnosis of disorders such as a tumor, stroke, dementia, stroke, and sleep disorders among others. It is also used for observing blood flow to the brain during surgery.
The increasing occurrence of neurological diseases, the inclusion of electroencephalography under Medicare, and growing investments in the development of advanced healthcare equipment by governments and private organizations are some factors expected to fuel the demand for electroencephalography devices during the forecast period.
Technological advancements and significant investments in research and development support market growth. New product launches and acquisitions by leading players in the market have increased the demand for electroencephalography devices across the globe. In December 2019, Ceribell, Inc introduced a new bedside EEG monitoring and alerting technology called Clarity to be integrated with its Rapid Response EEG system.
Know more about this report: request for sample pages
The new technology is aimed at offering 24/7 EEG monitoring and alerting in reduced time. The technology is developed for the detection of seizures and forwarding alerts to clinicians. The solution is equipped with a brain stethoscope feature for spot-checking of seizures, whereas the integration of Clarity provides automatic and continuous seizure monitoring.
Electroencephalography devices offer non-invasive analysis of spontaneous brain activity and high temporal resolution. Conventional EEG includes placing electrodes on the scalp for recording brain activity and can be combined with video monitoring to analyze abnormal brain waves during specific activities. Ambulatory electroencephalography devices require the patient to wear certain equipment for recording continuous brain activity.
Market players are investing in the development of advanced products to cater to the growing demands. In September 2019, Nihon Kohden introduced VitalEEG wireless electroencephalogram headset in the U.S. The EEG is designed to analyze brain-wave information of unconscious patients. The system provides a quick and easy assessment of brain health for the determination of treatment options. The system is equipped with Bluetooth connectivity to offer remote access to clinicians. This new addition enhances the company’s offerings in the market while strengthening its market presence.
The global electroencephalography (EEG) devices market is fueled by the growth in the healthcare sector in countries such as China, Japan, and India, technological advancements, and growing investments in research and development. Global players are expanding into developing countries to tap market potential, further boosting the market growth. Governments across the globe are introducing strict healthcare regulations, encouraging market players to develop effective and patient-friendly electroencephalography devices.
The market is primarily segmented on the basis of modality, product, application, end-use, and region:
Know more about this report: request for sample pages
The market is segmented into portable and standalone based on modality. The standalone devices segment dominated the global EEG devices market in 2020 owing to greater reliability, and improved efficiency. Standalone devices are widely used in hospitals and diagnostic centers to enhance patient experience and offer highly effective output. The increasing geriatric population, changing lifestyles, and growing occurrence of neurological disorders have increased the demand for standalone electroencephalography devices.
On the basis of application, the market is segmented into trauma and surgery, disease diagnosis, anesthesia monitoring, sleep monitoring, and others. Electroencephalography devices are used for sleep monitoring for clinical and research purposes. These devices are used to analyze sleep patterns to detect and study sleeping disorders such as insomnia, sleep paralysis, and sleep apnea among others. It is used to monitor sleep stages and cycles to analyze disruptions in sleeping patterns. Technological advancements have increased the adoption of electroencephalography devices in experiments and trials associated with sleep research.
The market is segmented into 8-channel EEG, 21-channel EEG, 25-channel EEG, 32-channel EEG, 40-channel EEG, and Multichannel EEG, based on product. The 32-channel EEG segment dominated the global electroencephalography (EEG) systems market in 2020. The 32-channel EEG system is widely used owing to its efficiency, ease of use, and high output.
The end-use segment has been divided into hospitals, clinics, oncology diagnostic centers, and others. The hospital segment dominated the global electroencephalography (EEG) systems market in 2020. The wide adoption of electroencephalography devices in hospitals is owing to factors such as advanced healthcare infrastructure, increasing geriatric population, and availability of advanced medical devices. The presence of experienced medical professionals and the emergence of hospitals in developing economies further boost the growth of this segment.
North America dominated the global electroencephalography (EEG) systems market in 2020. Increasing research and development activities, and technological advancements are some factors attributed to the growth of this regional segment. Increasing cases of neurological disorders, the inclusion of brain monitoring under medical insurance, and established healthcare infrastructure support the market growth. Significant investments in neurological research and growing awareness regarding the early diagnosis of diseases have increased the demand for electroencephalography devices in the region.
The leading players in the electroencephalography (EEG) devices market include Medtronic, Cadwell Laboratories, Inc., Neurosoft Ltd., Compumedics Ltd., Elekta AB, NeuroWave Devices, Inc., Electrical Geodesics, Inc., BrainScope Company Inc., Koninklijke Philips, Natus Medical, Inc., Nihon Kohden America, Inc., Noraxon U.S.A., Inc., Lifelines Neurodiagnostic Devices Inc., Bio-Signal Group Corp., Jordan NeuroScience Inc., and Cephalon A/S.